Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization
- PMID: 10679223
- DOI: 10.1006/bbrc.2000.2123
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization
Abstract
Sulfae conjugation is an important pathway in the metabolism of a large number of exogenous and endogenous compounds. These reactions are catalyzed by sulfotransferase (SULT) enzymes that utilize 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfate donor. PAPS is synthesized from ATP and inorganic sulfate by PAPS synthetase (PAPSS). Two separate PAPSS cDNAs, PAPSS1 and PAPSS2, have been identified in human tissues. We have cloned and characterized the genes for human PAPSS1 and PAPSS2 to make it possible to study the pharmacogenomics of these enzymes. Both genes consisted of 12 exons with virtually identical exon-intron splice junction locations. All splice junctions conformed to the "GT-AG" rule. The total length of PAPSS1 was approximately 108 kb, while that of PAPSS2 was greater than 37 kb. The 5'-flanking region of PAPSS1 did not include a TATA box sequence near the site of transcription initiation, but PAPSS2 had a TATA motif located 21 bp upstream from the site of transcription initiation. Northern blot analysis showed that the major PAPSS1 and PAPSS2 transcripts were approximately 2.7 and 4.2 kb in length, respectively. PAPSS1 mapped to human chromosome band 4q24 while PAPSS2 mapped to 10q22-23 by fluorescence in situ hybridization analysis. Cloning and structural characterization of PAPSS1 and PAPSS2 will make it possible to perform molecular genetic and pharmacogenomic studies of these important enzymes in humans.
Copyright 2000 Academic Press.
Similar articles
-
Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency.IUBMB Life. 2003 Jan;55(1):1-11. doi: 10.1080/1521654031000072148. IUBMB Life. 2003. PMID: 12716056 Review.
-
Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo.Dev Dyn. 2007 May;236(5):1313-8. doi: 10.1002/dvdy.21137. Dev Dyn. 2007. PMID: 17436279
-
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes.Pharmacogenetics. 2002 Jan;12(1):11-21. doi: 10.1097/00008571-200201000-00003. Pharmacogenetics. 2002. PMID: 11773860
-
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.Drug Metab Dispos. 2001 Feb;29(2):172-8. Drug Metab Dispos. 2001. PMID: 11159808
-
Melting Down Protein Stability: PAPS Synthase 2 in Patients and in a Cellular Environment.Front Mol Biosci. 2019 May 3;6:31. doi: 10.3389/fmolb.2019.00031. eCollection 2019. Front Mol Biosci. 2019. PMID: 31131283 Free PMC article. Review.
Cited by
-
Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases.Pharmacol Ther. 2023 Nov;251:108540. doi: 10.1016/j.pharmthera.2023.108540. Epub 2023 Sep 28. Pharmacol Ther. 2023. PMID: 37777160 Free PMC article. Review.
-
Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease.Genome Res. 2002 Jun;12(6):868-84. doi: 10.1101/gr.229002. Genome Res. 2002. PMID: 12045141 Free PMC article.
-
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study.Eur J Hum Genet. 2009 Oct;17(10):1250-9. doi: 10.1038/ejhg.2009.48. Epub 2009 Apr 1. Eur J Hum Genet. 2009. PMID: 19337310 Free PMC article.
-
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.Front Mol Biosci. 2025 Feb 3;12:1529507. doi: 10.3389/fmolb.2025.1529507. eCollection 2025. Front Mol Biosci. 2025. PMID: 39963268 Free PMC article.
-
From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function.Drug Metab Dispos. 2022 Jul;50(7):1027-1041. doi: 10.1124/dmd.121.000478. Epub 2022 Feb 22. Drug Metab Dispos. 2022. PMID: 35197313 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous